Investor profile
Innovestor Life Science Fund has backed 3 European tech companies across 3 funding rounds between 2023 and 2026, joining rounds totalling €141M. Most active in Healthtech. Data as of 11 Oct 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Breye Therapeutics | Denmark | 1 | €68M |
| AnaCardio | Sweden | 1 | €63M |
| HVR Cardio | Finland | 1 | €11M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| HVR Cardio | Series B | €11M | 2023-01 |
